Immunosuppressive drug used to prevent graft-versus-host disease ( Prograf®) . Alternative for cyclosporine
A medicine that slows down the body's immune system and helps protect your new organ from being rejected. Also known as Prograf®. . . . . . . . . . . . . . . . . . . . .
An immunosuppressive medication used for the Edmonton protocol. Although it is less toxic to islets than other medications, it may still play a role in the eventual failure of many transplants. Also called FK506.
Also known as FK506, this is an immuno-suppressive drug that is derived from a soil fungus. Its primary use has been in preventing organ rejection in transplant patient but most recently it has been approved by the FDA for use in certain dermatological conditions like atopic dermatitis. It has been thought that it could grow hair since it acts in a similar way to Cyclosporin, another powerful and toxic immuno-suppressive drug.
Also known as FK506 and its product name Prograf, tacrolimus is one of the major immune suppressing drugs used by transplant recipients to prevent organ rejection. Jump to Top
Medication used to prevent rejection of a transplanted kidney.
An immune suppressant similar to cyclosporine.
drug the helps keep the body from rejecting a transplanted organ Brand name is Prograf
A drug that suppresses the immune system and is used to prevent rejection following organ transplantation.
A drug that suppresses the immune system and prevents transplant rejection . The drug acts by inhibiting the activation of T cells . See the entire definition of Tacrolimus
Tacrolimus, or FK506, is an immunosuppressive polypeptide drug that inactivates T cells by inhibiting signal transduction from the T-cell receptor. Tacrolimus and cyclosporin A are the most commonly used immunosuppressive drugs in organ transplantation.
A drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.